Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Nonseminomatous germ cell tumor × Brentuximab Vedotin × 1 year × Clear all

Sponsor

Conditions

Hodgkin Disease 16 Lymphoma 6 Lymphoma, T-Cell, Cutaneous 5 Lymphoma, T-Cell 5 Mycosis Fungoides 4 Lymphoma, T-Cell, Peripheral 4 Lymphomatoid Papulosis 3 Lymphoma, Large-Cell, Anaplastic 3 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2 Lymphoma, Primary Cutaneous Anaplastic Large Cell 2 Lymphoma, Non-Hodgkin 2 Lymphoma, Large B-Cell, Diffuse 2 Immunoblastic Lymphadenopathy 2 Hematologic Diseases 2 Enteropathy-Associated T-Cell Lymphoma 2 Squamous Cell Carcinoma of Head and Neck 1 Sezary Syndrome 1 Recurrence 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Neoplasms 1 Mesothelioma, Malignant 1 Melanoma 1 Lymphoma, Follicular 1 Lymphoma, Extranodal NK-T-Cell 1 Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8 1 Leukemia, Large Granular Lymphocytic 1 Leukemia 1 Carcinoma, Non-Small-Cell Lung 1 Ann Arbor Stage IIB Hodgkin Lymphoma 1

Interventions

Drug Therapy 2 tremelimumab 1 fludarabine phosphate 1 fludarabine 1 durvalumab 1 cabozantinib 1 Etoposide 1 Cyclophosphamide 1 BEP protocol 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡